Detalhe da pesquisa
1.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell
; 184(9): 2316-2331.e15, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773105
2.
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell
; 184(7): 1804-1820.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691139
3.
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.
Cell
; 184(17): 4414-4429.e19, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416146
4.
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell
; 184(17): 4430-4446.e22, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416147
5.
The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.
Cell
; 182(4): 901-918.e18, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668198
6.
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
Cell
; 182(3): 744-753.e4, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553273
7.
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
Cell
; 183(1): 169-184.e13, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32931734
8.
Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Nat Immunol
; 21(11): 1470, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879513
9.
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Nat Immunol
; 21(11): 1327-1335, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839612
10.
A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Nat Immunol
; 20(10): 1291-1298, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31477918
11.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
; 54(10): 2399-2416.e6, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481543
12.
Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.
Immunity
; 54(6): 1290-1303.e7, 2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022127
13.
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Nature
; 591(7849): 293-299, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33494095
14.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
; 596(7870): 103-108, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153975
15.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature
; 584(7821): 443-449, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668443
16.
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
J Virol
; 96(1): e0151121, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668780
17.
MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2.
PLoS Pathog
; 16(1): e1008292, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999809
18.
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
J Immunol
; 205(4): 915-922, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591393
19.
Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques.
J Infect Dis
; 221(9): 1506-1517, 2020 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616920
20.
Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron.
bioRxiv
; 2022 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118466